瑞格列奈是一类被称为美格利尼德的抗糖尿病药物,在1983发明.瑞格列奈是一种口服药物,除了饮食和运动外,还用于控制2型糖尿病的血糖.瑞格列奈的作用机制包括促进胰腺β胰岛细胞释放胰岛素；与其他抗糖尿病药物一样,主要的副作用令人担忧.低血糖.诺和诺德在美国以普兰丁、加拿大的葡萄糖诺、日本的Surepost、EIPICO在埃及的Repaglinide、其他地方的NovoNorm的名义销售.在日本,它是由日本住友制药公司生产的.
-
98% CAS No.:99469-99-5 -
SKU-Pack Size Availability Price（￥） Quantity R6106887-1g In-Stock(Shanghai or CA Irwindale) R6106887-5g In-Stock(Shanghai or CA Irwindale) R6106887-10g In-Stock(Shanghai or CA Irwindale) R6106887-25g In-Stock(Shanghai or CA Irwindale) R6106887-100g In-Stock(Shanghai or CA Irwindale) -
≥99% CAS No.:50-85-1 -
SKU-Pack Size Availability Price（￥） Quantity R000079-5g In-Stock(Shanghai or CA Irwindale) R000079-500g In-Stock(Shanghai or CA Irwindale) R000079-100g In-Stock(Shanghai or CA Irwindale) R000079-25g In-Stock(Shanghai or CA Irwindale) R000079-5g In-Stock(Shanghai or CA Irwindale) R000079-500g In-Stock(Shanghai or CA Irwindale) R000079-100g In-Stock(Shanghai or CA Irwindale) R000079-25g In-Stock(Shanghai or CA Irwindale) R000079-5g In-Stock(Shanghai or CA Irwindale) R000079-500g In-Stock(Shanghai or CA Irwindale) R000079-100g In-Stock(Shanghai or CA Irwindale) R000079-25g In-Stock(Shanghai or CA Irwindale) R000079-5g In-Stock(Shanghai or CA Irwindale) R000079-500g In-Stock(Shanghai or CA Irwindale) R000079-100g In-Stock(Shanghai or CA Irwindale) R000079-25g In-Stock(Shanghai or CA Irwindale) R000079-5g In-Stock(Shanghai or CA Irwindale) R000079-25g In-Stock(Shanghai or CA Irwindale) R000079-100g In-Stock(Shanghai or CA Irwindale) R000079-500g In-Stock(Shanghai or CA Irwindale) -
97% CAS No.:88709-17-5 -
SKU-Pack Size Availability Price（￥） Quantity R439767-250mg In-Stock(Shanghai or CA Irwindale) R439767-1g In-Stock(Shanghai or CA Irwindale) R439767-5g In-Stock(Shanghai or CA Irwindale) R439767-10g In-Stock(Shanghai or CA Irwindale)